Seeking Alpha

Catalyst Pharmaceutical Partners (CPRX -1.9%) slips into the red after opening +8% on the back...

Catalyst Pharmaceutical Partners (CPRX -1.9%) slips into the red after opening +8% on the back of its earlier announcement that the independent Data Monitoring Committee overseeing CPRX's Phase III clinical trials of Firdapse, a potential treatment for Lambert-Easton Myasthenic Syndrome, gave the go-ahead to continue the trial as planned based on a review of safety and clinical data.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|